Look at the incentives for starters:
MD = 11c by end of the year
latest cap raise = 4c option within 2 years
Personally i still think 100M cap or 7.6c (inc. latest options) on current in-ground assets is fair, but clearly "the market" thinks that's frivolous.
Getting healthily above 4c so that people exercise their options will raise another $3.5M, so an obvious management target. However, will add many more shares to wash through at that level.
A 4-5c range, presuming all those raise options are exercised, would be around 52 to 65M cap.
Getting to Robert's incentive of 11c would imply a cap of 143M, somewhat ambitious from here. But if they enter arrangements to sell Opuwo in Q3, JV Sagay, and complete PFS on MCB and earn some permits, all within 2022, perhaps not out of the question. Would require a complete 180 in sentiment.
- Forums
- ASX - By Stock
- Ann: Celsius Begins Drilling at Opuwo Cobalt Project
CLA
celsius resources limited.
Add to My Watchlist
0.00%
!
0.7¢

Look at the incentives for starters:MD = 11c by end of the...
Featured News
Add to My Watchlist
What is My Watchlist?
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
|
|||||
Last
0.7¢ |
Change
0.000(0.00%) |
Mkt cap ! $21.94M |
Open | High | Low | Value | Volume |
0.7¢ | 0.7¢ | 0.7¢ | $10.64K | 1.529M |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
35 | 17227406 | 0.6¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
0.7¢ | 2496518 | 3 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
32 | 15644073 | 0.006 |
21 | 11672526 | 0.005 |
4 | 2760009 | 0.004 |
5 | 4070000 | 0.003 |
5 | 5900001 | 0.002 |
Price($) | Vol. | No. |
---|---|---|
0.007 | 2496518 | 3 |
0.008 | 1720949 | 7 |
0.009 | 9032380 | 7 |
0.010 | 2512433 | 8 |
0.011 | 4725263 | 4 |
Last trade - 11.42am 04/07/2025 (20 minute delay) ? |
Featured News
CLA (ASX) Chart |
The Watchlist
NUZ
NEURIZON THERAPEUTICS LIMITED
Dr Michael Thurn, CEO & MD
Dr Michael Thurn
CEO & MD
SPONSORED BY The Market Online